Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harmless is a UK-based social enterprise and healthcare service provider that specializes in self-harm and suicide prevention. The organization provides a range of therapeutic services, including one-to-one support, clinical intervention, and peer-led groups for individuals at risk. Beyond direct patient care, Harmless acts as a center of excellence, offering CPD-accredited training and consultancy to healthcare professionals and educators to improve the national response to self-harm. Their business model integrates clinical expertise with lived experience to deliver evidence-based, compassionate care across the East Midlands and beyond.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harmless Products.